The nurse is instructed to give an antihistamine in the form of an orally disintegrating tablet to a client. Which of the following is a recommended guideline for administration of this form of medication?
A) Place the tablet under the client's tongue.
B) Place the tablet between the client's tongue and cheek.
C) Instruct the client to break up the tablet by chewing it.
D) Place the tablet on the client's tongue to dissolve instantly.
D
Feedback:
The orally disintegrating tablet (ODT) is an excellent choice for noncompliant clients and small children. This tablet is placed on the client's tongue and it dissolves instantly, thus ensuring medication compliance. Sublingual medications are administered under the tongue. Buccal administration involves placing the medication between the client's cheek and gum. The client should be instructed not to chew or break up the ODT tablet, because this interferes with the timing of the drug's release.
You might also like to view...
The nurse is providing education to the client with multiple burns and lists the options for skin grafting and application techniques. Which is the primary benefit for using an autograft slit graft versus other types of grafts?
A) Less scarring B) Less discomfort C) Speeds healing D) Rejection is unlikely.
A public health nurse has been asked to give an educational presentation on aging to the senior citizens at the senior citizens center
The nurse would include in her presentation information on sensory losses due to aging. Since reaction to painful stimuli is an important warning signal, what must be used with caution when treating the elderly? A) Hot or cold packs B) Analgesics C) Anti-inflammatory medications D) Whirlpool baths
The nurse is caring for a postsurgical patient whose surgical procedure lasted 3 hours. The nurse anticipates that the patient will experience:
a. thrombophlebitis. b. muscle spasms. c. joint pain. d. hyperthermia.
The nurse understands that exenatide is:
a. an oral hypoglycemic agent used to treat type 2 diabetes. b. an oral insulin used to treat people with type 1 diabetes. c. a parenteral treatment for people with type 2 diabetes. d. a rapid-acting insulin used to treat people with type 1 diabetes.